1999

1. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia

   Blood, Vol. 94, Núm. 9, pp. 3015-3021